PATENT CLAIM ANALYSIS

Application Number: 15903744
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["435", "135000"]

Abstract:
This document describes biochemical pathways for producing 2,4-pentadienoyl-CoA by forming one or two terminal functional groups, comprised of carboxyl or hydroxyl group, in a C5 backbone substrate such as glutaryl-CoA, glutaryl-[acp] or glutarate methyl ester. 2,4-pentadienoyl-CoA can be enzymatically converted to 1,3-butadiene.

Claim (Index 37):
The method of  claim 35 , wherein the prokaryote is selected from the group consisting of  Escherichia coli, Clostridium ljungdahlii, Clostridium autoethanogenum, Clostridium kluyveri, Corynebacterium glutamicum, Cupriavidus necator, Cupriavidus metallidurans. Pseudomonas fluorescens, Pseudomonas putida, Pseudomonas oleavorans, Delftia acidovorans, Bacillus subtillis, Lactobacillus delbrueckii, Lactococcus lactis,  and  Rhodococcus equi.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.13636
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14741414', '14741259', '14740554', '14139072', '14740749']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6839954692005806
- 35 USC 102 Novelty (BERT): 0.6895268100966926
- Combined Prediction Score: 0.6845486032901918
- Mean Citation Score: 625.527602
- Max Citation Score: 844.33905
- Similarity Product: 689.8935751551033

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test